August 2012
-
Hovione has announced that the FDA has found its Loures, Portugal manufacturing site to be GMP compliant, although the agency issued a Form 483 citing three inspectional observations. The inspection took place from December 1… Read more . . .
-
Submit poster abstracts by May 31, 2015. More information available at http://www.tefarco.it/TB2015/pages/posters.aspx# Read more . . .
-
Lightlake Therapeutics has agreed to license its intranasal naloxone for opioid overdose reversal to Adapt Pharma for possible development and sales milestones of more than $55 million, plus royalties, the company said. Lightlake recently announced… Read more . . .
-
GSK has announced that it will change the color of the Relvar Ellipta fluticasone/vilanterol DPI starting in January 2015. The company said that it will remove the color blue from the inhaler and its packaging… Read more . . .
-
Acorda Therapeutics has announced the enrollment of the first patient in a Phase 3 study of CVT-301 inhaled L-dopa for the treatment of OFF episodes in Parkinson’s disease (PD). The study is expected to enroll… Read more . . .
-
Cystic Fibrosis Foundation Therapeutics (CFFT), a nonprofit associated with the Cystic Fibrosis Foundation, has announced that it will provide Shire with up to $15 million for development of an aerosol messenger RNA therapy designed to… Read more . . .
-
Submit podium abstracts by March 9, 2015 and poster abstracts by May 9 2015 at http://www.inhalationasia.org/conference/inhalation-asia-15/present. Inhalation Asia offers open access to its conference archive; authors must consent to making presentations and/or posters available at… Read more . . .
-
Pfizer has launched Novartis’ Ultibro Breezhaler indacaterol/glycopyrronium DPI for the treatment of COPD in the UK, the company said. Ultibro Breezhaler was approved in Europe in September 2013. In September 2014, Pfizer announced that it… Read more . . .
-
Submit 3-5 page double-space poster abstracts by January 9, 2015 online at http://www.rddonline.com/rdd/poster_reg.php?id=11. Poster guidelines can be found at http://www.rddonline.com/rdd/rdd.php?id=11&sid=4&sub=358 Read more . . .
-
RDD Online and Aptar Pharma have announced that registration is now open for Respiratory Drug Delivery (RDD) Europe 2015, to be held May 5-8, 2015 in Antibes, France. This will be the 10th anniversary of… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland